Form 4: Allient Inc. Executive Stephen Warzala Reports Acquisition of Restricted Stock
SEC Form 4 Filing
Allient Inc.'s VP and Group President, Stephen Warzala, acquired 3,000 shares of restricted stock on December 30, 2024, according to a recent SEC filing.
Summary
- Stephen Warzala, VP and Group President at Allient Inc., reported the acquisition of 3,000 shares of common stock on December 30, 2024.
- These shares were granted as time-based restricted stock under the company's 2017 Omnibus Incentive Plan.
- The restricted shares will vest in three equal installments on December 31, 2025, 2026, and 2027.
- Mr. Warzala also indirectly owns 110,000 shares through a trust where he is a co-trustee and beneficiary, 2,801 shares through a trust where he is a trustee, and 4,001 shares through an ESOP trust.
Sentiment
Score: 7
Explanation: The document is a routine disclosure of an executive stock grant, which is generally neutral to positive. It indicates alignment of interests between management and shareholders.
Positives
- The grant of restricted stock aligns Mr. Warzala's interests with the long-term performance of the company.
- The vesting schedule encourages continued service and contribution from the executive.
Industry Context
This filing is a routine disclosure of insider transactions, which is common for publicly traded companies. It provides transparency into executive compensation and ownership.
Comparison to Industry Standards
- The use of restricted stock as part of executive compensation is a standard practice across many industries.
- Vesting schedules, such as the one described, are also common to incentivize long-term performance and retention.
- Many companies in the technology and manufacturing sectors use similar incentive plans.
Stakeholder Impact
- The stock grant may have a slightly positive impact on shareholder sentiment as it aligns executive interests with company performance.
Key Dates
| Date | Description |
|---|---|
| 12/30/2024 | Date of the restricted stock grant to Stephen Warzala. |
| 12/31/2025 | First vesting date for one-third of the restricted shares. |
| 12/31/2026 | Second vesting date for one-third of the restricted shares. |
| 12/31/2027 | Final vesting date for the remaining one-third of the restricted shares. |
| 01/02/2025 | Date the SEC Form 4 was signed. |
Keywords
insider trading, SEC Form 4, restricted stock, stock grant, executive compensation, Allient Inc., ALNT, Stephen Warzala
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.